Drug Report History #2471
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that have changed between versions will be highlighted in yellow, and the changes will be clearly marked as updated.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow, and the change will be clearly marked as updated.
| Field | Version v2-EN | Version v1-EN |
|---|---|---|
| Language | English | English |
| Date Updated | 2017-04-06 (Updated) | 2017-03-14 |
| Drug Identification Number | 02373130 (Updated) | 00001686 |
| Brand name | XYLOCAINE 2% WITH EPINEPHRINE 1:200000 (Updated) | XYLOCAINE VISCOUS 2% |
| Common or Proper name | Lidocaine Hydrochloride and Epinephrine Bitartrate Injection (Updated) | lidocaine hydrochloride solution |
| Company Name | ASTRAZENECA CANADA INC | ASTRAZENECA CANADA INC |
| Ingredients | LIDOCAINE HYDROCHLORIDE EPINEPHRINE RACEMIC (Updated) | LIDOCAINE HYDROCHLORIDE |
| Strength(s) | 20MG 0.005MG (Updated) | 20MG |
| Dosage form(s) | SOLUTION (Updated) | LIQUID |
| Route of administration | BLOCK/INFILTRATION (Updated) | ORAL TOPICAL |
| Packaging size | 20 mL (Updated) | 100 mL |
| ATC code | N01BB | N01BB |
| ATC description | ANESTHETICS, LOCAL | ANESTHETICS, LOCAL |
| Reason for shortage | Delay in shipping of the drug. (Updated) | Shortage of an inactive ingredient or component. |
| Anticipated start date | (Updated) | 2017-03-14 |
| Actual start date | 2017-04-05 (Updated) | |
| Estimated end date | 2017-04-21 (Updated) | Unknown |
| Actual end date | ||
| Shortage status | Actual shortage (Updated) | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | ||
| Health Canada comments |